Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

117
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
GlaxoSmithKline plc : Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Sales27 38726 43126 50523 88725 08426 000
Operating income (EBITDA)10 2319 4158 8838 0248 4018 923
Operating profit (EBIT)8 5548 3308 0156 8227 2697 648
Pre-Tax Profit (EBT)7 6986 6926 6475 1725 7196 317
Net income5 2614 5655 6284 0384 3494 973
EPS (PNC)10391,511183,2105105
Dividend per Share (PNC)70,074,078,077,479,886,5
Yield4,95%5,23%5,51%5,47%5,64%6,11%
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Finances - Leverage
GlaxoSmithKline plc : Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201120122013201420152016
Debt9 00314 03712 64512 70611 10111 572
Finance------
Operating income (EBITDA)10 2319 4158 8838 0248 4018 923
Leverage
(Debt/EBITDA)
0,88x1,49x1,42x1,58x1,32x1,30x
Capital Expenditure9231 0511 1881 3501 3821 273
Book Value Per Share (BVPS)162 PNC120 PNC146 PNC137 PNC129 PNC140 PNC
Cash Flow per Share124 PNC87,7 PNC149 PNC120 PNC127 PNC150 PNC
Announcement Date02/07/2012
12:00pm
02/06/2013
12:01pm
02/05/2014
12:00pm
---
Balance Sheet Analysis
GlaxoSmithKline plc : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 68 588 M GBP -
Entreprise Value (EV) 81 294 M GBP 79 689 M GBP
Valuation 2014e 2015e
PER (Price / EPS) 17,0x 13,5x
Capitalization / Revenue 2,87x 2,73x
EV / Revenue 3,40x 3,18x
EV / EBITDA 10,1x 9,49x
Yield (DPS / Price) 5,47% 5,64%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 28,6% 29,0%
operating Leverage (Delta EBIT / Delta Sales) -1,51x 1,31x
Net Margin (Net Profit / Revenue) 16,9% 17,3%
ROA (Net Profit / Asset) 7,90% 7,90%
ROE (Net Profit / Equities) 64,2% 70,6%
Rate of Dividend 93,1% 76,3%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   5,65% 5,51%
Cash Flow / Sales (Taux d'autofinancement) 24,3% 24,5%
Capital Intensity (Assets / Sales) 2,14x 2,19x
Financial Leverage (Net Debt / EBITDA) 1,58x 1,32x
Price Earning Ratio
GlaxoSmithKline plc : Price Earning Ratio
EPS & Dividend
GlaxoSmithKline plc : EPS Dividend
Dynamic quotes  
ON
| OFF